Hasselle, M. D., Rusthoven, K. E., Macrie, B. D., Shah, N., Golden, D. W., Weichselbaum, R. R., & Salama, J. K. (2010). Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma. In Journal of Clinical Oncology (Vol. 28, pp. e18049–e18049). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.e18049

Hasselle, M. D., K. E. Rusthoven, B. D. Macrie, N. Shah, D. W. Golden, R. R. Weichselbaum, and J. K. Salama. “Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma.” In Journal of Clinical Oncology, 28:e18049–e18049. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.e18049.

Hasselle MD, Rusthoven KE, Macrie BD, Shah N, Golden DW, Weichselbaum RR, et al. Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. e18049–e18049.

Hasselle, M. D., et al. “Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. e18049–e18049. Crossref, doi:10.1200/jco.2010.28.15_suppl.e18049.

Hasselle MD, Rusthoven KE, Macrie BD, Shah N, Golden DW, Weichselbaum RR, Salama JK. Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. e18049–e18049.